LINDSEY UNDERDOWN: Open Payments
NPI 1376315457 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,656 in 89 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,012 · 2025 $1,656
Food & beverage: $1,656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $270 |
| Novo Nordisk Inc | 10 | $200 |
| PFIZER INC. | 13 | $170 |
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $130 |
| Axsome Therapeutics, Inc. | 5 | $113 |
| Lilly USA, LLC | 5 | $76 |
| SANOFI-AVENTIS U.S. LLC | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| SHIELD THERAPEUTICS INC | 2 | $62 |
Products named: VRAYLAR, NURTEC ODT, CAPLYTA, Auvelity, Wegovy, TZIELD, QULIPTA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
